TNFRSF4 and primary cutaneous T-cell non-Hodgkin lymphoma: The OX-40 axis was identified as a key driver of CTCL progression, promoting tumor growth and metastasis through ERK activation while validating the chick embryo model as a preclinical tool for therapeutic testing.